Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-06-06T08:57:46.986Z Has data issue: false hasContentIssue false

Renal haemodynamic effects of B2 receptor agonist bradykinin and B2 receptor antagonist HOE 140 in conscious lambs

Published online by Cambridge University Press:  10 January 2001

Avni Patel
Affiliation:
Departments of Physiology and Biophysics/Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1
Francine G. Smith
Affiliation:
Departments of Physiology and Biophysics/Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1
Get access

Abstract

The present study was designed to test the hypothesis that the high renal vascular resistance characteristic of the newborn results from age-dependent changes in the responsiveness of the renal vasculature to kinins. Two studies were carried out in conscious, chronically instrumented lambs aged 1 and 6 weeks. Firstly, we measured the renal blood flow response to intra-arterial injection of the B2 receptor agonist bradykinin over the range of doses 0-800 ng kg-1. The ED50 renal blood flow response to bradykinin was 50 ng kg-1 in both age groups of lambs. Secondly, we measured the effects of intravenous administration of 12.5 µg kg-1 of the specific B2 receptor antagonist HOE 140; this dose attenuated the renal blood flow response to 50 ng kg-1 of bradykinin in both age groups. HOE 140 administration was associated with an age-dependent increase in mean arterial pressure, with little effect on heart rate or renal vascular resistance. This study provides new information regarding the effects of kinins in modulating renal haemodynamics during postnatal maturation. We reject our hypothesis and conclude that the high renal vascular resistance of the newborn does not appear to result from age-dependent changes in the responsiveness of the renal vasculature to endogenous kinins.

Type
Research Article
Copyright
© The Physiological Society 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)